Xybion Digital Acquires Autoscribe Limited for US$15M
November 16, 2023
Xybion Digital Inc. completed the acquisition of Autoscribe Limited, a UK‑headquartered LIMS software company, for an aggregate purchase price of US$15 million (US$12.094M at closing plus three deferred US$1M payments). The acquisition was funded in part by a new up-to US$15M senior secured credit facility arranged with Capital Finance Opportunities 2303F LLC; Autoscribe reported roughly US$6.18M revenue and an adjusted EBITDA of US$0.678M for the fiscal year ended March 31, 2023.
- Buyers
- Xybion Digital Inc.
- Targets
- Autoscribe Limited
- Sellers
- Shareholders of Autoscribe Limited
- Industry
- Software
- Location
- Berkshire, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Instem Acquires Xybion Digital from Banerjee Group LLC
July 31, 2025
Cloud & SaaS
Instem has closed the acquisition of Xybion Digital (Xybion), the maker of the Pristima preclinical study management platform, from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee. The deal expands Instem's SaaS capabilities in preclinical R&D and LIMS, adds significant pharmaceutical and CRO customers across more than 30 countries, and brings Xybion's advisory services and Autoscribe LIMS into Instem's portfolio.
-
ACL Digital Acquires Symbiance
September 26, 2025
Healthcare Services
ACL Digital, an ALTEN Group company, has acquired Symbiance, a US-based contract research organization (CRO) that provides clinical data management, biostatistics, medical writing and pharmacovigilance services. The acquisition expands ACL Digital's life sciences capabilities by adding AI-driven clinical research, CRO and pharmacovigilance expertise to its digital transformation and engineering services.
-
Agilent Technologies Acquires e-MSion
March 9, 2023
Medical Devices
Agilent Technologies has acquired e-MSion, the early-stage company behind the ExD cell electron capture dissociation (ECD) technology for benchtop mass spectrometers. The purchase brings e-MSion's ExD cell and associated tools into Agilent's life-sciences instrument portfolio to expand biopharma characterization capabilities and make ECD accessible to a broader set of labs.
-
Astellas Pharma Acquires Xyphos Biosciences
December 26, 2019
Biotechnology
Astellas Pharma has acquired Xyphos Biosciences, gaining Xyphos' ACCEL convertible-CAR technology platform and immuno-oncology talent. The deal included $120 million paid at closing and potential milestone payments bringing the total transaction value to up to $665 million.
-
Spectris plc Acquires SciAps Incorporated
August 21, 2024
Manufacturing
Spectris plc agreed to acquire SciAps Incorporated for up to $260 million (upfront $200M plus up to $60M deferred), integrating the handheld XRF and LIBS specialist into Malvern Panalytical. SciAps, based in Boston, Massachusetts, is a high-growth provider of handheld materials-analysis instruments (expected 2024 sales ~$70M and adjusted EBITDA ~$12.1M); Rand Capital received $13.1M in proceeds from the sale of its SciAps investments.
-
DocuSign Acquires Lexion for $165M
May 6, 2024
Cloud & SaaS
DocuSign has agreed to acquire Lexion, a Seattle-based AI-powered contract and agreement management startup, for $165 million in cash. The acquisition will fold Lexion's AI-driven contract understanding, drafting and workflow capabilities into DocuSign's Intelligent Agreement Management (IAM) platform to accelerate product innovation and deepen AI capabilities for customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.